Riverside most recently entrusted the team with two sales: the sale
of haematology specialist Diatron to a subsidiary of STRATEC Biomedical and the sale of the shareholding in TRANSPOREON Group to TPG Capital.
Department
of Haematology and Genetic Pathology, Flinders University and Medical Centre, Bedford Park, SA, Australia.
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK, and in the Department
of Haematology, University of Cambridge.
Director of the Cancéropôle PACA Member of the Henry Kunkel Society Member of the American Society
of Haematology See biography...
Department
of Haematology, University of Cambridge, Addenbrookes Hospital, Cambridge CB2 0XY, United Kingdom.
Department
of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department
of Haematology, University of Cambridge, Cambridge CB2 2XY, UK.
Department
of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0 PT, UK.
The journal's contribution to advancing the field
of haematology is the reason why it is read by haematologists, clinical pharmacologists, cardiologists, surgeons, internal specialists and laboratory physicians
Professor Smith is a Consultant Paediatric Haematologist at Our Lady's Children's Hospital Dublin, and is Professor
of Haematology at the University of Dublin, Trinity College Dublin.
Department
of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
Topic: Extending the reach of molecular replacement in Phaser Presenter: Randy Read, Wellcome Trust Principal Research Fellow in the Department
of Haematology at University of Cambridge.
I am a resident doctor in the department
of haematology and oncology in the Georg - August University Hospital in Göttingen, Germany.
Among these was the annual American Society
of Haematology meeting in San Francisco in 2000.
Not exact matches
The pharmaceutical company Amgen admitted that «over the past decade its oncology and
haematology researchers could not replicate 47
of 53 highly promising results they examined,» and this is apparently typical.
Institute researchers Dr Ashley Ng, Dr Maria Kauppi, Professor Warren Alexander, Professor Don Metcalf and colleagues from the institute's Cancer and
Haematology and Molecular Medicine divisions led the research, published in the journal Proceedings
of the National Academy
of Sciences.
Bayer's rival Amgen reported an even higher rate
of failure — over the past decade its oncology and
haematology researchers could not replicate 47
of 53 highly promising results they examined (Nature, vol 483, p 531).
The targeted therapy everolimus may be safely combined with R - CHOP for new, untreated diffuse large B - cell lymphoma according to the results
of a pilot study by Mayo Clinic researchers published in the Lancet
Haematology.
The researchers, led by Professor Sten Eirik W Jacobsen at the MRC Molecular
Haematology Unit and the Weatherall Institute for Molecular Medicine at the University
of Oxford, investigated malignant cells in the bone marrow
of patients with myelodysplastic syndrome (MDS) and followed them over time.
A new test may reveal which patients will respond to treatment for graft versus host disease (GVHD), an often life - threatening complication
of stem cell transplants (SCT) used to treat leukemia and other blood disorders, according to a study led by researchers at the Icahn School
of Medicine at Mount Sinai and published online today in the journal Lancet
Haematology and in print in the January issue.
In a study recently published in the journal Experimental
Haematology, the group demonstrate that is wide variation in BCR - ABL expression levels in the cell model and the stickier cells have a higher level
of BCR - ABL expression.
Co-authors
of the study were Giovanni Cazzaniga, PhD, Maria Daniotti, BSc, Giuseppe Masera, MD, and Andrea Biondi, MD,
of Centro Ricerca Tettamanti, Clinica Pediatrica, Universita di Milano, Ospedale San Gerardo, Milan, Italy; Osborn B. Eden, FRCP,
of the Academic Unit
of Paediatric Oncology, Christie Hospital NHS Trust, Manchester, UK; G. M. Addison, FRCPath,
of the Department
of Clinical Biochemistry, Royal Manchester Children's Hospital, Manchester; and V. Saha, FRCPCH,
of the Department
of Paediatric
Haematology and Oncology, Royal London Hospital, London.
Phenotyping: neurobiology and behaviour, cognition, cardiovascular system, exploration
of lung functions,
haematology and clinical chemistry, metabolic exploration, histopathology and embryology
The main databases devoted stricto sensu to cancer cytogenetics are the «Mitelman Database
of Chromosome Aberrations and Gene Fusions in Cancer» (http://cgap.nci.nih.gov/Chromosomes/Mitelman), the «Atlas
of Genetics and Cytogenetics in Oncology and
Haematology» (http://atlasgeneticsoncology.org), and COSMIC (http://cancer.sanger.ac.uk/cosmic).
Table 1:
Haematology and blood biochemistry
of dogs with non-specific dietary sensitivity (McNeill et al. 2001)
Helen has a very busy clinical liability practice including cases involving obstetrics, neurosurgery, neurology, oncology, cardiology, ophthalmology,
haematology, dermatology, out
of hours primary care, neurology, A&E and general practice.
For example, Mitchell et al estimated that the prevalence
of depression in oncology and
haematology patients was 9.6 % — 16.5 %.5 Depression is a significant comorbidity
of chronic medical disorders.